News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
1–30
Matches
30
Sources here
19
Companies here
2
Search results Stored financial headlines

Active search

30 matching headlines

Ticker or company: OPTHMain company stories
Clear
Latest

MarketBeat Deals and strategy

Top Optimi Health (OPTH) Competitors 2026

This article analyzes Optimi Health (OPTH) against its main competitors in the pharmaceuticals industry: Rafael (RFL), ImmuCell (ICCC), Cognition Therapeutics (CGTX), PolyPid (PYPD), and RF Acquisition Corp II (RFAI). The comparison is based on factors such as profitability, valuation, earnings, analyst recommendations, institutional ownership, and media sentiment. While Optimi Health shows some strengths, such as higher media sentiment …

Main company 🇺🇸 United States
Read at MarketBeat
Sharemaestro market context Stored weekly price path 13 weeks -18.1% · Next-week setup positive 57.5% OPTH stored weekly price path from 22 May 2026 to 14 Aug 2026
Just inNext headlines
kalkine.ca Market update Main company 🇺🇸 United States

Optimi Health Corp. Establishes US$100 Million Discretionary Equity Line of Credit with Seven Knots

Optimi Health Corp. has secured a discretionary equity line of credit of up to US$100 million with Seven Knots, LLC, providing flexible capital for its psychedelic pharmaceutical operations. The agreement allows Optimi to sell common shares to Seven Knots at its discretion, with individual …

OPTH main company
Sharemaestro market context Stored weekly price path 13 weeks -18.1% · Next-week setup positive 57.5% OPTH stored weekly price path from 22 May 2026 to 14 Aug 2026

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Stock Titan Earnings Main company 🇺🇸 United States

Optimi Health (OPTH) raises $20.7M, posts larger loss and builds cash buffer

Optimi Health (OPTH) reported a wider net loss of $5.6 million for the nine months ending June 30, 2026, despite securing $20.7 million in gross proceeds from a Nasdaq public offering. Revenue decreased to $239,700 from $490,330 in the prior year, attributed to Australian …

OPTH main company
Sharemaestro market context Stored weekly price path 13 weeks -18.1% · Next-week setup positive 57.5% OPTH stored weekly price path from 22 May 2026 to 14 Aug 2026
Stock Titan Balance sheet Main company 🇺🇸 United States

Optimi Health (OPTH) secures US$100M equity line with convertible note sweeteners

Optimi Health Corp. (OPTH) has secured a US$100 million discretionary equity line of credit with Seven Knots, LLC, allowing Optimi to sell common shares over time at its discretion. As part of the agreement, Optimi issued a US$1.5 million unsecured, non-interest-bearing convertible note and …

OPTH main company
Sharemaestro market context Stored weekly price path 13 weeks -18.1% · Next-week setup positive 57.5% OPTH stored weekly price path from 22 May 2026 to 14 Aug 2026
kalkine.ca Market update Main company 🇺🇸 United States

Optimi Health Stock Slides 3.4% on August 11 — Is This Psychedelics Manufacturer Getting Interesting Again?

Optimi Health Corp. (CN: OPTI) shares dropped 3.4% on August 11, 2026, without a clear company-specific reason, highlighting the volatility of the psychedelics sector. The company, which manufactures pharmaceutical-grade psilocybin and MDMA, has achieved operational milestones including production runs, product launches, and an export …

OPTH main company
Sharemaestro market context Stored weekly price path 13 weeks -18.1% · Next-week setup positive 57.5% OPTH stored weekly price path from 22 May 2026 to 14 Aug 2026
kalkine.ca Regulatory and legal Main company 🇺🇸 United States

Optimi Health Corp (CN:OPTI) Shares Under Pressure as Psychedelic Market Uncertainty and Development Risks Weigh on Sentiment

Optimi Health Corp (CN:OPTI) shares recently declined by 2.40% due to investor caution surrounding the psychedelic medicine market, regulatory uncertainties, and broader biotechnology sector volatility. The company, which manufactures and distributes pharmaceutical-grade psychedelic products like psilocybin, faces challenges in market adoption, funding, and competition. …

OPTH main company
Sharemaestro market context Stored weekly price path 13 weeks -18.1% · Next-week setup positive 57.5% OPTH stored weekly price path from 22 May 2026 to 14 Aug 2026
Stock Titan Deals and strategy Main company 🇺🇸 United States

Optimi Health Corp. (OPTH) investor reports 8.25% beneficial stake via Cathay Visions

Cathay Visions Enterprises Inc. and its sole owner, Dane Nicholas Stevens, have reported an 8.25% beneficial ownership stake in Optimi Health Corp. (OPTH) through a Schedule 13G filing. This holding comprises 456,347 common shares and options/warrants exercisable for an additional 17,777 common shares, totaling …

OPTH main company
Sharemaestro market context Stored weekly price path 13 weeks -18.1% · Next-week setup positive 57.5% OPTH stored weekly price path from 22 May 2026 to 14 Aug 2026
Stock Titan Market update Main company 🇺🇸 United States

Optimi Health (OPTH) CEO adds 3,800 shares at CDN$6.70

Optimi Health Corp.'s CEO, Dane Stevens, purchased 3,800 common shares at CDN$6.70 per share on August 5, 2026, through Cathay Visions Enterprises Ltd. This open market transaction increases his beneficial ownership to 456,347 common shares. The insider trade was disclosed in a Form 6-K …

OPTH main company
Sharemaestro market context Stored weekly price path 13 weeks -18.1% · Next-week setup positive 57.5% OPTH stored weekly price path from 22 May 2026 to 14 Aug 2026
The Canadian Securities Exchange (CSE) Regulatory and legal Main company 🇺🇸 United States

CSE Filings for Optimi Health Corp.

This page from the Canadian Securities Exchange (CSE) provides access to regulatory filings for Optimi Health Corp. (OPTI). It details the company's active status, industry (Life Sciences), issued and outstanding shares, and offers various filtering options to search through different types of CSE and …

OPTH main company
Sharemaestro market context Stored weekly price path 13 weeks -18.1% · Next-week setup positive 57.5% OPTH stored weekly price path from 22 May 2026 to 14 Aug 2026
TradingView Earnings Main company 🇺🇸 United States

Optimi Health Corp. Revenue Breakdown – CSE:OPTI

This article provides a brief overview of Optimi Health Corp.'s (CSE:OPTI) revenue breakdown, highlighting that Canada was the primary contributor to its revenue in the last two fiscal years. In the most recent year, Canada accounted for 426.30K CAD, a slight increase from the …

OPTH main company
Sharemaestro market context Stored weekly price path 13 weeks -18.1% · Next-week setup positive 57.5% OPTH stored weekly price path from 22 May 2026 to 14 Aug 2026
Simply Wall Street Earnings Main company 🇺🇸 United States

OPTH: A licensed manufacturer already selling MDMA while peers still wait on trials

Optimi Health (NASDAQ: OPTH) is presented as a unique investment opportunity in the psychedelic biotechnology sector, distinguishing itself as a commercial-stage manufacturer of pharmaceutical-grade psilocybin and MDMA, rather than a drug developer reliant on clinical trials. The article highlights Optimi's established licensing, vertical integration, …

OPTH main company
Sharemaestro market context Stored weekly price path 13 weeks -18.1% · Next-week setup positive 57.5% OPTH stored weekly price path from 22 May 2026 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context